ArticleGynecologic oncology2025

The impact of antibiotics, proton pump inhibitors, H2-receptor antagonists, and steroids on survival in ovarian cancer patients receiving PARP inhibitor therapy.

Quinn Kistenfeger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.